Sources from the US Department of Health said. The US government has announced a further ban on AstraZeneca from entering the Emergent BioSolutions vaccine facility in Baltimore. After the incident that caused the COVID-19 vaccine There was a damage of 15 million doses in the factory.
The US government has announced that Johnson & Johnson (J&J) will take over the facility in place of AstraZeneca. Johnson & Johnson will be fully responsible for the Emergent BioSolutions facility and will deliver 100 million doses of the COVID-19 vaccine to the US government by the end of May.
AstraZeneca revealed that The company will continue to work with the US government to find new facilities to manufacture the company's vaccines.
The news marks AstraZeneca's new barrier to vaccine production in the United States. After US authorities criticized the company for using old data to disclose the เกม slotxo results of the COVID-19 vaccine trial, As many European countries have suspended previous vaccinations of AstraZeneca. After a report of death from a thromboembolic attack after vaccination.
The US Food and Drug Administration (FDA) has not yet approved the use of the COVID-19 vaccine. Of AstraZeneca in any way